Campuses:

neoantigen

Saturday, September 16, 2017 - 11:20am - 11:50am
Yi-Hsiang Hsu (Harvard Medical School)
The fast moving of the cancer immunotherapy field has generated tremendous excitement regarding new therapeutic strategies and will likely change the paradigm of therapeutic interventions for cancer. Neoantigens, generated by tumor-specific DNA alterations that result in the formation of novel protein sequences and only in cancer cells, represent an optimal target for the immune system and make possible a new class of highly personalized vaccines with the potential for significant efficacy with reduced side effects.
Subscribe to RSS - neoantigen